EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The role of abnormal ubiquitination in hepatocellular carcinoma pathology

Ming Zhang, Tingju Wei, Danfeng Guo

Cellular Signalling · 2024-02 · 114 · 110994

DOI: 10.1016/j.cellsig.2023.110994 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2024-02. Verfasst von Ming Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Key …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer is known for its high incidence and fatality rate. Over the years, therapeutic strategies for primary liver cancer have advanced significantly. Nonetheless, a substantial number of patients have not benefited from these methods, underscoring the pressing need for new and effective treatments for primary liver cancer. Ubiquitination is a critical post-translational modification that enables proteins to fulfill their normal biological functions and maintain their expression stability within cells. Importantly, increasing evidence suggests that the progression of liver cancer cells is often accompanied by disruptions in protein ubiquitination and deubiquitination processes. In this comprehensive review, we have compiled pertinent research about dysregulated ubiquitination in hepatocellular carcinoma (HCC) to broaden our understanding in this field. We elucidate the connections between the ubiquitination proteasome system, deubiquitination, and HCC. Furthermore, we shed light on the role of ubiquitination in cells situated within the tumor microenvironment of HCC including its involvement in mediating the activation of oncogenic pathways, reprogramming metabolic processes, and perturbing normal cellular functions. In conclusion, targeting the dysregulation of ubiquitination in HCC holds promise as a prospective and complementary therapeutic approach to existing treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansProspective StudiesUbiquitinationProtein Processing, Post-TranslationalTumor Microenvironment

Stichwörter der Autor:innen

Hepatocellular carcinomaTumor microenvironmentUbiquitin-ligating enzymesUbiquitination

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Henan Key Laboratory for Digestive Organ Transplantation, the First Affiliated H…
  • Department of Cardiac Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.

Förderung

  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Zhang, M., Wei, T., & Guo, D. (2024). The role of abnormal ubiquitination in hepatocellular carcinoma pathology. Cellular Signalling, 114, 110994. https://doi.org/10.1016/j.cellsig.2023.110994

Vancouver

Zhang M, Wei T, Guo D. The role of abnormal ubiquitination in hepatocellular carcinoma pathology. Cellular Signalling. 2024;114:110994. doi:10.1016/j.cellsig.2023.110994

BibTeX
@article{Zhang2024,
  author = {Zhang, Ming and Wei, Tingju and Guo, Danfeng},
  title = {The role of abnormal ubiquitination in hepatocellular carcinoma pathology},
  journal = {Cellular Signalling},
  year = {2024},
  volume = {114},
  pages = {110994},
  doi = {10.1016/j.cellsig.2023.110994}
}
Kostenlos starten →